MW 319.32 Da, Purity >99%. Selective OX1 receptor antagonist. Inhibits orexin-A induced intracellular calcium release (IC50 = 226 nM). Shows anxiolytic, sedative and anorectic effects *in vivo.*.
5 HT 2B receptor, 5 HT(2B), 5 Hydroxytryptamine 2C receptor, 5 hydroxytryptamine (serotonin) receptor 2B, 5 hydroxytryptamine (serotonin) receptor 2B G protein coupled, 5 hydroxytryptamine 2B receptor, 5-HT-1C, 5-HTR2C, 5-ht-1c receptor, 5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled, 5-hydroxytryptamine receptor 1C, 5-hydroxytryptamine receptor 2B, 5-hydroxytryptamine receptor 2C, 5HT2B_HUMAN, 5HT2C_HUMAN, 5HT2F, A2AAR, A2aR, AA2AR_HUMAN, ADENO, ADORA 2, ADORA2A, AI838772, AW493413, Adenosine A2 receptor, Adenosine A2a receptor, Adenosine receptor A2a, Adenosine receptor subtype A2a, CP2D6_HUMAN, CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, CYPIID6, Cholesterol 25-hydroxylase, Cytochrome P450 2D6, Cytochrome P450 family 2 subfamily D member 6, Cytochrome P450 family 2 subfamily D polypeptide 6, Cytochrome P450-DB1, Debrisoquine 4-hydroxylase, FLJ11090, HCRTR 1, HTR2C, Hcr tr2, Hcrt receptor 2, Htr 2b, Htr1c, Hypocretin (orexin) receptor 2, Hypocretin receptor 2, Hypocretin receptor type 1, Hypocretin receptor type 2, MGC104252, MGC112732, Microsomal monooxygenase, NP75 protein, OX1R_HUMAN, OX2R_HUMAN, Orexin 2 receptor, Orexin A/Orexin B receptor, Orexin Receptor 1, Orexin receptor 2, Orexin receptor type 1, Orexin receptor type 2, Orexin type 2 receptor, P450 DB1, P450C2D, RDC 8, RP24-311F12.2, SCAN1, SEROTONIN 5HT2B RECEPTOR, Serotonin 5-HT-2C receptor, Serotonin receptor 2B, Serotonin receptor 2C, Stomach fundus serotonin receptor, TYDP, TYDP1_HUMAN, Type 2 hypocretin receptor, Type 2 orexin receptor, Tyr-DNA phosphodiesterase 1, Tyrosyl-DNA phosphodiesterase 1, Xenobiotic monooxygenase, flavoprotein-linked monooxygenase, hA2aR, serotonin 1c receptor, serotonin 2c receptor
MW 319.32 Da, Purity >99%. Selective OX1 receptor antagonist. Inhibits orexin-A induced intracellular calcium release (IC50 = 226 nM). Shows anxiolytic, sedative and anorectic effects *in vivo.*.
Soluble in ethanol to 10 mM.
Soluble in DMSO to 100 mM.
Selective OX1 receptor antagonist. Inhibits orexin-A induced intracellular calcium release (IC50 = 226 nM). Shows anxiolytic, sedative and anorectic effects *in vivo.*
The TDP1 protein also known as Tyrosyl-DNA Phosphodiesterase 1 plays a significant role in DNA repair by resolving DNA damage. This enzyme with a molecular mass of approximately 68 kDa is present in various tissues including the brain and peripheral tissues. Another target CYP2D6 an important enzyme in drug metabolism has a molecular mass of about 50 kDa and is predominantly found in the liver. In contrast Adenosine Receptor A2a a G protein-coupled receptor is distributed in the brain and blood vessels. The serotonin receptors 5-HT-2B and 5-HT2C also G-protein coupled reside in the central nervous system. Orexin Receptors 1 and 2 known as Ox-1-R and Ox-2-R respectively have an important presence in the brain particularly in the hypothalamus actively influencing wakefulness and appetite.
The TDP1 enzyme helps maintain genomic integrity by repairing topoisomerase-induced DNA strand breaks and is not part of a larger complex. CYP2D6 significantly contributes to the metabolism of therapeutic drugs and toxins activating prodrugs into active compounds. The Adenosine Receptor A2a primarily mediates vasodilation and neuronal signaling often interacting with dopamine receptors. 5-HT-2B and 5-HT2C receptors modulate neurotransmitter release impacting mood and cognition. Orexin Receptors 1 and 2 critical for sleep regulation and feeding behavior interact with neuropeptides that control arousal and energy balance.
TDP1 participates in the DNA repair pathway importantly counteracting damage due to DNA topoisomerase 1. This maintenance of DNA integrity aligns with proteins like PARP1 involved in the repair of single-strand breaks. CYP2D6 figures prominently in the xenobiotic metabolism pathway processing a wide array of exogenous substances alongside other cytochrome P450 enzymes. The Adenosine Receptor A2a is part of the cAMP signaling pathway interacting with important proteins like G-proteins to regulate various physiological processes. Serotonin receptor 5-HT-2B is associated with the serotonin signaling pathway interconnected with proteins modulating synaptic transmission. Orexin Receptors 1 and 2 are integral to the orexin/hypocretin pathway interacting with various signaling proteins to maintain energy homeostasis.
TDP1 mutations associate with neurodegenerative diseases like spinocerebellar ataxia with axonal neuropathy (SCAN1) where DNA repair deficiencies manifest. PARP1 closely involved with TDP1 similarly associates with neurodegenerative conditions. Abnormal CYP2D6 activity results in varied drug metabolism linking it to disorders like depression and treatment-related adverse drug reactions. The Adenosine Receptor A2a has associations with Parkinson's disease impacting dopaminergic neurotransmission. In the realm of mood disorders the dysregulation of 5-HT2C receptors reveals a connection with obesity and type 2 diabetes highlighting its role in psychiatric conditions. Orexin Receptors 1 and 2 present connections to sleep disorders like narcolepsy impacting neuromodulators that regulate sleep-wake cycles.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
2D chemical structure image of ab120164, SB 334867, OX1 receptor antagonist
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com